ReviewAntioxidants & redox signaling2014

Molecular mechanisms of action and therapeutic uses of pharmacological inhibitors of HIF-prolyl 4-hydroxylases for treatment of ischemic diseases.

Vaithinathan Selvaraju et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.